Detalles de la búsqueda
1.
Repurposing the ß3-Adrenergic Receptor Agonist Mirabegron in Patients With Structural Cardiac Disease: The Beta3-LVH Phase 2b Randomized Clinical Trial.
JAMA Cardiol
; 8(11): 1031-1040, 2023 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37728907
2.
A Three-Month Consumption of Eggs Enriched with ω-3, ω-5 and ω-7 Polyunsaturated Fatty Acids Significantly Decreases the Waist Circumference of Subjects at Risk of Developing Metabolic Syndrome: A Double-Blind Randomized Controlled Trial.
Nutrients
; 13(2)2021 Feb 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33670720
3.
Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertrophy (Beta3-LVH).
ESC Heart Fail
; 5(5): 830-841, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29932311
Resultados
1 -
3
de 3
1
Próxima >
>>